Accelerated lung aging in patients with morbid obesity
Saulo Maia D'Ávila Melo1, Valdinaldo Aragão de Melo, Enaldo Vieira de Melo
1Hospital Universitário, Universidade Federal de Sergipe, e Hospital Governador João Alves Filho, Aracaju, SE, Brasil. smaia@infonet.com.br
Summary
Morbid obesity significantly accelerates lung aging, with patients exhibiting a lung age considerably older than their chronological age. This indicates premature lung damage, highlighting the need for obesity management to preserve pulmonary health.
Area of Science:
- Pulmonology
- Obesity Medicine
- Gerontology
Background:
- Morbid obesity is associated with numerous health complications.
- Pulmonary function can be impaired in obese individuals, but the extent of accelerated lung aging is not fully understood.
Purpose of the Study:
- To determine the lung age of patients with morbid obesity.
- To compare lung age with chronological age in this population.
- To highlight the premature lung damage caused by morbid obesity.
Main Methods:
- A prospective cross-sectional study involving 112 individuals (78 morbidly obese, 34 controls).
- Spirometry was performed to determine lung age.
- Lung age and chronological age were compared within and between groups.
Main Results:
- Patients with morbid obesity showed a significant increase in lung age compared to their chronological age (mean difference 9.1 years).
- Lung age was significantly higher in the morbidly obese group compared to the control group (mean difference 12.2 years).
- Lung age positively correlated with chronological age and body mass index (BMI), and negatively with spirometric variables.
Conclusions:
- Morbid obesity leads to accelerated lung aging and premature lung damage.
- Lung age determination may serve as a valuable tool for assessing pulmonary function in obesity.
- Understanding lung age can aid in managing obesity and its respiratory consequences.
Related Concept Videos
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:20COPD: Pathogenesis and Clinical Features
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...